blog

Industry insights from our own scientists, publicists, developers, designers, strategists and more.

Our experts have spent their careers learning their craft, honing their skills and implementing the most effective marketing, engagement and public relations strategies to help healthcare and science brands transform the world. Let's dive in, shall we?

Our latest posts

A stylized rendering of red blood cells

Changing the DNA of medicine with the world’s first CRISPR therapy

Friday was a monumental day for those living with sickle cell and those pursuing cell and gene therapy solutions for various diseases.

Katy Steele, Scientific Content Writer | December 12, 2023

FDA | FDA Approved

A photo of various pharmacy drugs arranged around the FDA approval stamp.

Regulatory Review: Unsung FDA approvals for rare disease in the 3rd quarter

In Q3 2022, several rare disease therapies became the first approved for their indications. Read more about under-the-radar FDA approvals for rare disease.

Katy Steele, Scientific Content Writer | October 18, 2022

FDA | FDA Approved | Rare Disease